Streetbeat News

Products Services

VERA

Vera Therapeutics has completed enrollment for the primary endpoint in its Phase 3 ORIGIN 3 trial of atacicept for IgAN, with results expected in Q2 2025. The company will also present data from a Phase 2b trial in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:01 pm

GLD

NVDA

SPY

USO

U.S. markets closed higher with strong gains in the technology sector, led by Nvidia. Inflation data showed a 0.2% increase in CPI for August. Asian markets were mixed, while European markets advanced. Crude oil and gold prices rose due to disruptions in U.S. Gulf production.

Portfolio Pulse from Akanksha Bakshi

September 12, 2024 | 12:00 pm

WKSP

Worksport Ltd (NASDAQ:WKSP) reported a significant increase in sales for August 2024, reaching $1.21 million, which boosts their Annual Recurring Revenue to $14.56 million. The company is on track to exceed its 2024 revenue guidance and aims for cash flow positivity by 2025. Worksport's CEO highlights the company's undervaluation and potential for growth, especially with upcoming product lines like AL4, SOLIS, and COR. Despite positive news, WKSP stock closed 3.34% lower at $0.4926.

Portfolio Pulse from Anusuya Lahiri

September 12, 2024 | 12:00 pm

AIBD

AIBU

AMD

NVDA

NVIDIA and AMD stocks rose significantly amid potential export approvals to Saudi Arabia and interest in OpenAI's equity raise. Direxion's AI and Big Data Bull and Bear ETFs offer traders opportunities to capitalize on AI market trends.

Portfolio Pulse from Joshenomoto@benzinga.com

September 12, 2024 | 11:49 am

N2OFF

N2OFF shares rise following the announcement of a potential 10% capacity increase in its Solar PV Joint Venture Project with Solterra Renewable Energy.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:44 am

AURA

Aura Biosciences shares rose following the announcement of positive Phase 2 study results for bel-sar, a treatment for early-stage choroidal melanoma.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:43 am

ACN

Aramco Digital and Accenture have formed a strategic partnership to drive generative AI innovation and enhance digital skills in Saudi Arabia, aligning with the Kingdom's Vision 2030.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:41 am

OSK

Oshkosh Corporation has received a $72.9 million order from the US Army Contracting Command for additional Family of Medium Tactical Vehicles A2. This order supports the U.S. Army's modernization strategy and enhances Oshkosh's role in military readiness.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:39 am

FULC

Fulcrum Therapeutics' shares fell after the company's Phase 3 REACH trial for losmapimod in FSHD patients failed to meet its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:39 am

REGN

SNY

Health Canada has expanded the approval of Sanofi and Regeneron's Dupixent for treating eosinophilic esophagitis in younger patients, aged 1 year and older, weighing at least 15 kg.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:38 am